Description
Phase
Phase 1/2 - for trials that are a combination of phases 1 and 2.Inclusion and Exclusion Criteria
Please contact Poornima Murali to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- USC/Kenneth Norris Comprehensive Cancer Center USC 2, Los Angeles, California, 90033
- USC/Kenneth Norris Comprehensive Cancer Center USC 2, Los Angeles, California, 90033
- University of California at Los Angeles Dept. of UCLA, Los Angeles, California, 90095
- University of California at Los Angeles Dept. of UCLA, Los Angeles, California, 90095
-
Utah
- University of Utah / Huntsman Cancer Institute Onc Dept, Salt Lake City, Utah, 84103
-
Tennessee
- Sarah Cannon Research Institute SCRI SC, Nashville, Tennessee, 37203
- Sarah Cannon Research Institute SCRI SC, Nashville, Tennessee, 37203
- Vanderbilt University Medical Center SC-5, Nashville, Tennessee, 37232
-
AN
- Novartis Investigative Site, Ancona, AN, 60126
- Novartis Investigative Site, Ancona, AN, 60126
-
Germany
- Novartis Investigative Site, Essen, 45147
- Novartis Investigative Site, Essen, 45147
Powered by
SC CTSI